Your search history is turned on.
Date: January 19, 2024 Jurisdictions: Quebec
Amend Report of Exempt Distribution Form 45-106F1 Form 45-106F1 Report of Exempt Distribution ITEM 1 REPORT TYPE New report Amended report If amended, provide filing date of report that is being amended. 2022 12 23 (YYYY-MM-DD) ITEM 2 PARTY CERTIFYING THE REPORT Indicate the party certifying the report (select only one). For guidance regarding whet...
Date: March 3, 2023 Jurisdictions: All jurisdictions
Four Diagnostic Products in the Pipeline at SQI Four Diagnostic Products in the Pipeline at SQI TORONTO, March 3, 2023 /CNW/ - SQI Diagnostics Inc. (TSX-V: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests, today announced it is developing three diagnostic products based on University Health Network (UHN) innovat...
Date: March 1, 2023 Jurisdictions: All jurisdictions
SQI Diagnostics Reports First Quarter 2023 Results SQI Diagnostics Reports First Quarter 2023 Results TORONTO, March 1, 2023 /CNW/ - SQI Diagnostics Inc. (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests today reported its financial and operational results for the first quarter ended December 31, 2022. ...
Date: March 1, 2023 Jurisdictions: Alberta, British Columbia, Ontario
FORM 52-109FV2 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Morlan Reddock, Chief Financial Officer of SQI Diagnostics Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of SQI Diagnostics Inc. (the issuer) for the interim peri...
FORM 52-109FV2 FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Andrew Morris, Chief Executive Officer of SQI Diagnostics Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of SQI Diagnostics Inc. (the issuer) for the interim perio...
Microsoft Word - Dec 31 2022 Q1 MDA FY 2023 March 1 2023 Final SQI DIAGNOSTICS INC. Managements Discussion and Analysis of Financial Condition and Results of Operations For the three months ended December 31, 2022 2 Managements Discussion and Analysis of Financial Condition And Results of Operations This Managements Discussion and Analys...
Microsoft Word - Financial Statements December 31 2022 March 1 2023 Final v2 Clean SQI Diagnostics Inc. Condensed Interim Consolidated Financial Statements (Unaudited) (Expressed in Canadian dollars) For the Three Months Ended December 31, 2022, and 2021 Notice to Reader The accompanying unaudited financial statements have been prepared by managemen...
Date: February 28, 2023 Jurisdictions: All jurisdictions
SQI DIAGNOSTICS EXTENDS MATURITY DATE OF PIVOT CREDIT FACILITY SQI DIAGNOSTICS EXTENDS MATURITY DATE OF PIVOT CREDIT FACILITY /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA/ TORONTO, Feb. 28, 2023 /CNW/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufac...
Date: February 21, 2023 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - Form 45-102F1 (Wilmot Matthews - SQI) (Feb 2023)(52171207.2) FORM 45-102F1 Notice of Intention to Distribute Securities under Section 2.8 of NI 45-102 Resale of Securities Reporting issuer 1. Name of reporting issuer: SQI Diagnostics Inc. Selling security holder 2. Your name: Wilmot L. Matthews (Mr. Matthews). 3. The off...
Microsoft Word - Form 45-102F1 (Gerry Connor - SQI) (Feb 2023)(52171206.2) FORM 45-102F1 Notice of Intention to Distribute Securities under Section 2.8 of NI 45-102 Resale of Securities Reporting issuer 1. Name of reporting issuer: SQI Diagnostics Inc. Selling security holder 2. Your name: Gerald R. Connor (Mr. Connor). 3. The offices or...